Clinical Trials Study
Copyright ©The Author(s) 2025.
World J Hepatol. May 27, 2025; 17(5): 105890
Published online May 27, 2025. doi: 10.4254/wjh.v17.i5.105890
Table 1 Baseline characteristics of the three subgroups, n (%)
Characteristic
Reoperative laparoscopic left lateral sectionectomy (n = 40)
Reoperative laparoscopic left hemihepatectomy (n = 50)
Reoperative laparoscopic complex hepatectomy (n = 11)
χ²/F value
P value
Male9 (22.5)16 (32.0)4 (36.4)1.3330.5141
Age, mean (SD), years62.3 (11.5)61.8 (7.8)60.0 (7.7)0.2610.7712
Body mass index > 21.5 kg/m218 (45.0)25 (50.0)6 (54.5 )0.4020.8181
American Society of Anesthesiologists score 2-321 (52.5)19 (38.0)5 (45.5)1.8950.3881
Obstructive jaundice6 (15.0)11 (22.0)2 (18.2)0.7160.6991
Benign liver lesions32 (80.0)43 (86.0)9 (81.8)0.5880.7451
Number of previous surgeries > 22 (5.0)1 (2.0)0 (0.0)N/A30.706
Types of previous procedureN/A30.250
cholecystectomy29 (72.5)28 (56.0)9 (81.8)
Choledochotomy with exploration11 (27.5)19 (38.0)2 (18.0)
Hepatectomy0 (0.0)3 (6.0)0 (0.0)
Types of previous approachN/A30.789
Open surgery30 (75.0)40 (80.0)9 (81.8)
Laparoscopic surgery9 (22.5)7 (14.0)2 (18.0)
Unclear1 (2.5)3 (6.0)0 (0.0)
Interval between last two surgeriesN/A30.608
≤ 2 years3 (7.5)8 (16.0)2 (18.2)
> 2 years30 (75.0)37 (74.0)8 (72.7)
Unknown time-interval7 (17.5)5 (10.0)1 (9.1)
Table 2 Clinical outcomes of the three types of laparoscopic reoperation
Characteristic
Reoperative laparoscopic left lateral sectionectomy (n = 40)
Reoperative laparoscopic left hemihepatectomy (n = 50)
Reoperative laparoscopic complex hepatectomy (n = 11)
χ²/H value
P value
Selective hepatic blood flow occlusion8/40 (20.0)47/50 (94.0)67/11 (63.6)6,751.364< 0.0011
Operation duration, median (IQR), minute240.0 (196.3-322.5)325.0 (254.5-387.8)6350.0 (295.0-460.0)614.5080.0012
Blood loss, median (IQR), mL200.0 (75.0-281.2)200.0 (100.0-400.0)400.0 (200.0-800.0)5.8370.0542
Blood transfusion4/40 (10.0)11/50 (22.0)66/11 (54.5)610.4830.0051
Conversion to open surgery3/40 (7.5)8/50 (16.0)4/11 (36.4)65.7870.0551
Postoperative intensive care unit stay5/40 (12.5)10/50 (20.0)7/11 (63.6)6,713.4260.0011
Postoperative stay, median (IQR), days8.0 (6.0-10.0)8.0 (7.0-12.3)10.0 (7.0-13.0)2.2110.3312
Early complications within 90 days17/40 (42.5)27/50 (54.0)7/11 (63.6)2.0280.3631
Major complications within 90 days2/40 (5.0)3/50 (6.0)0/11 (0.0)N/A31.000
Reinterventions within 90 days2/40 (5.0)3/50 (6.0)0/11 (0.0)N/A31.000
Readmission within 90 days6/40 (15.0)10/50 (20.0)3/11 (27.3)0.9420.6241
90-day mortality0/40 (0.0)0/50 (0.0)0/11 (0.0)--
Initial stone clearance433/40 (82.5)36/48 (75.0)8/11 (72.7)0.8930.6401
Re-treatment for residual stones42/40 (5.0)6/48 (12.5)1/11 (9.1)N/A30.412
Final stone clearance434/40 (85.0)39/48 (81.3)8/11 (72.7)0.8940.6401
Stone recurrence52/34 (5.9)2/39 (5.1)0/8 (0.0)N/A31.000
Late complications41/40 (2.5)3/48 (6.3)1/11 (9.1)N/A30.411
Late major complications40/40 (0.0)1/48 (2.1)0/11 (0.0)N/A31.000
Secondary ICC41/40 (2.5)0/48 (0.0)0/11 (0.0)N/A30.515
Late death due to complications or ICC41/40 (2.5)0/48 (0.0)0/11 (0.0)N/A30.515
Table 3 Clinical outcomes of the two subgroups of reoperative left lateral sectionectomy
Clinical outcomes
Reoperative open left lateral sectionectomy (n = 40)
Reoperative laparoscopic left lateral sectionectomy (n = 40)
χ²/Z value
P value
Selective hepatic blood flow occlusion5/40 (12.5)8/40 (20.0)0.8270.3631
Operation duration, median (IQR), minute200.0 (180.0-240.0)240.0 (196.3-322.5)-3.0730.0022
Blood loss, median (IQR), mL200.0 (81.3-300.0)200.0 (75.0-281.2)-0.7430.4572
Blood transfusion12/40 (30.0)4/40 (10.0)5.0000.0251
Conversion to open surgery-3/40 (7.5)--
Postoperative intensive care unit stay5/40 (12.5)5/40 (12.5)0.0001.0001
Postoperative hospital stay, median (IQR), days10.0 (8.0-17.0)8.0 (6.0-10.0)-3.3320.0012
Early complications within 90 days16/40 (40.0)17/40 (42.5)0.0520.8201
Major complications within 90 days1/40 (2.5)2/40 (5.0)N/A31.000
Reinterventions within 90 days1/40 (2.5)2/40 (5.0)N/A31.000
Readmission within 90 days5/40 (12.5)6/40 (15.0)0.1050.7451
90-day mortality0/40 (0.0)0/40 (0.0)--
Initial stone clearance rate429/39 (74.4)33/40 (82.5)0.7750.3791
Re-treatment of residual stones44/39 (10.3)2/40 (5.0)N/A30.432
Final stone clearance rate432/39 (85.0)34/40 (85.0)0.1250.7241
Stone recurrence59/32(28.1 )2/34 (5.9)5.8720.0151
Late complications41/39 (2.6)1/40 (2.5)N/A31.000
Late major complications41/39 (2.6)0/40 (0.0)N/A30.494
Secondary ICC44/39 (10.3)1/40 (2.5)N/A30.201
Late death due to complications or ICC44/39 (10.3)1/40 (2.5)N/A30.201
Table 4 Clinical outcomes of the two subgroups of reoperative left hemihepatectomy
Clinical outcomes
Reoperative open left hemihepatectomy (n = 33)
Reoperative laparoscopic left hemihepatectomy (n = 50)
χ²/t/Z value
P value
Selective hepatic blood flow occlusion29/33 (87.9)47/50 (94.0)0.9560.3261
Operation duration, mean (SD), minute244.7 (84.7)318.9 (88.5)-3.8000.0002
Blood loss, median (IQR), mL235.7 (150.0-400.0)200.0 (100.0-400.0)-1.4110.1583
Blood transfusion13/33 (39.4)11/50 (22.0)2.9260.0871
Conversion to open surgery-8/50 (16.0)--
Postoperative intensive care unit stay5/33 (15.2)10/50 (20.0)0.3160.5741
Postoperative hospital stay, median (IQR), days13.0 (8.0-21.0)8.0 (7.0-12.3)-3.2370.0013
Early complications within 90 days21/33 (63.6)27/50 (54.0)0.7570.3841
Major complications within 90 days1/33 (3.0)3/50 (6.0)N/A41.000
Reinterventions within 90 days1/33 (3.0)3/50 (6.0)N/A41.000
Readmission within 90 days6/33 (18.2)10/50 (20.0)0.0420.8371
90-day mortality0/33 (0.0)0/50 (0.0)--
Initial stone clearance rate525/32 (78.1)36/48 (75.0)0.1040.7481
Re-treatment of residual stones54/32 (12.5)6/48 (12.5)N/A31.000
Final stone clearance rate526/32 (81.3)39/48 (81.3)0.0001.0001
Stone recurrence68/26(30.8 )2/39 (5.1)N/A40.011
Late complications54/32 (12.5)3/48 (6.3)N/A40.429
Late major complications52/32 (6.3)1/48 (2.1)N/A40.561
Secondary ICC50/32 (0.0)0/48 (0.0)--
Late death due to complications or ICC51/32 (3.1)0/48 (0.0)N/A40.400